Clin Mol Hepatol.  2020 Jul;26(3):305-308. 10.3350/cmh.2020.0096.

Optimal sequence of systemic therapy after sorafenib failure in patients with hepatocellular carcinoma

Affiliations
  • 1Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea

Keyword

Carcinoma, Hepatocellular; Sorafenib; Protein kinase inhibitors
Full Text Links
  • CMH
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr